JP2006504794A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504794A5
JP2006504794A5 JP2005500032A JP2005500032A JP2006504794A5 JP 2006504794 A5 JP2006504794 A5 JP 2006504794A5 JP 2005500032 A JP2005500032 A JP 2005500032A JP 2005500032 A JP2005500032 A JP 2005500032A JP 2006504794 A5 JP2006504794 A5 JP 2006504794A5
Authority
JP
Japan
Prior art keywords
tetrahydro
amide
sulfonic acid
thiophene
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005500032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504794A (ja
Filing date
Publication date
Priority claimed from GB0223226A external-priority patent/GB0223226D0/en
Priority claimed from GB0223236A external-priority patent/GB0223236D0/en
Priority claimed from GB0314627A external-priority patent/GB0314627D0/en
Application filed filed Critical
Priority claimed from PCT/EP2003/011174 external-priority patent/WO2004031181A1/en
Publication of JP2006504794A publication Critical patent/JP2006504794A/ja
Publication of JP2006504794A5 publication Critical patent/JP2006504794A5/ja
Pending legal-status Critical Current

Links

JP2005500032A 2002-10-07 2003-10-06 抗精神病薬としてのスルホンアミド誘導体 Pending JP2006504794A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0223226A GB0223226D0 (en) 2002-10-07 2002-10-07 Compounds
GB0223236A GB0223236D0 (en) 2002-10-07 2002-10-07 Compouds
GB0314627A GB0314627D0 (en) 2003-06-23 2003-06-23 Novel compounds
PCT/EP2003/011174 WO2004031181A1 (en) 2002-10-07 2003-10-06 Sulfonamide derivatives as antipsychotic agents

Publications (2)

Publication Number Publication Date
JP2006504794A JP2006504794A (ja) 2006-02-09
JP2006504794A5 true JP2006504794A5 (cg-RX-API-DMAC7.html) 2006-11-02

Family

ID=32073912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005500032A Pending JP2006504794A (ja) 2002-10-07 2003-10-06 抗精神病薬としてのスルホンアミド誘導体

Country Status (8)

Country Link
US (1) US7122538B2 (cg-RX-API-DMAC7.html)
EP (1) EP1549639B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006504794A (cg-RX-API-DMAC7.html)
AT (1) ATE327234T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003273969A1 (cg-RX-API-DMAC7.html)
DE (1) DE60305519T2 (cg-RX-API-DMAC7.html)
ES (1) ES2264003T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004031181A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
US8207160B2 (en) 2003-12-18 2012-06-26 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
ATE487715T1 (de) * 2005-08-22 2010-11-15 Glaxo Group Ltd Triazolderivate als modulatoren von dopamin-d3- rezeptoren
EP1837332A1 (en) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
US7897595B2 (en) 2006-05-26 2011-03-01 Forest Laboratories Holdings Limited Pyridoazepine derivatives
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
CN110430875A (zh) 2017-01-13 2019-11-08 大日本住友制药株式会社 用于与帕金森病相关的非运动症状的治疗剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792785B (en) 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
GB9926302D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
CA2394603A1 (en) 1999-12-21 2001-06-28 Dashyant Dhanak Urotensin-ii receptor antagonists
DE10053799A1 (de) 2000-10-30 2002-05-08 Bayer Ag Verwendung von Tetrahydroisochinolinsulfonamiden
PL371344A1 (en) 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents

Similar Documents

Publication Publication Date Title
JP2007520440A5 (cg-RX-API-DMAC7.html)
JP2005518414A5 (cg-RX-API-DMAC7.html)
JP2005535586A5 (cg-RX-API-DMAC7.html)
JP2007505922A5 (cg-RX-API-DMAC7.html)
RU2439068C2 (ru) Модуляторы mglur5
JP2009520685A5 (cg-RX-API-DMAC7.html)
JP2005526723A5 (cg-RX-API-DMAC7.html)
JP2002534519A5 (cg-RX-API-DMAC7.html)
JP2009515980A5 (cg-RX-API-DMAC7.html)
JP2010527373A5 (cg-RX-API-DMAC7.html)
JP2004536869A5 (cg-RX-API-DMAC7.html)
RU2000105266A (ru) Производные 1-(n-фениламиноалкил)-пиперазина, замещенные в положении 2 фенильного кольца
JP2005527542A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
JP2012510989A5 (cg-RX-API-DMAC7.html)
JP2012520867A5 (cg-RX-API-DMAC7.html)
JP2005501120A5 (cg-RX-API-DMAC7.html)
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
JP2011500697A5 (cg-RX-API-DMAC7.html)
JP2011507868A5 (cg-RX-API-DMAC7.html)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
JP2002030084A5 (cg-RX-API-DMAC7.html)
JP2006507355A5 (cg-RX-API-DMAC7.html)
JP2005522452A5 (cg-RX-API-DMAC7.html)
JP2005511594A5 (cg-RX-API-DMAC7.html)